Skip to main content
Clinical Trials/NCT03954509
NCT03954509
Completed
N/A

Needs Assessment of Cancer Patients With Complementary and Alternative Medicines

Fondation Hôpital Saint-Joseph1 site in 1 country64 target enrollmentJuly 9, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
Fondation Hôpital Saint-Joseph
Enrollment
64
Locations
1
Primary Endpoint
Evaluation of the perception of patients regarding complementary and alternative medicines (CAM) in the management of cancer or its complications but also the place of different health professionals.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The chronic cancer status, multidisciplinary and ambulatory care, as well as the cumbersome effects of the disease and treatments, lead patients to consider other options than those offered by traditional medicine, such as alternative medicine and complementary (CAM)

Detailed Description

In order to put in place a policy on CAM based on the knowledge held by the patient and the health professionals, it is imperative to obtain and analyze the following information: why this type of medicine is used, what are its benefits, how does the patient get information and what are his sources, who practices them and how the patient perceives the place of the hospital and the various health professionals to develop and secure the use of CAM. Our study will focus on CAM that can bring iatrogenic risk (phytotherapy, food supplements, acupuncture, traditional Chinese medicine, homeopathy, essential oils), and the following techniques: hypnosis and sophrology. The study is carried out in two successive phases: the interview phase which will make it possible to obtain results to carry out the questionnaires phase. Patients who will be included in the interview phase will not participate in the questionnaire phase. Finally, patients who participate in the questionnaire phase will not have semi-structured interviews. They will only have to answer the questionnaire.

Registry
clinicaltrials.gov
Start Date
July 9, 2018
End Date
April 26, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Woman and man over 18
  • Francophone (speaking and reading French)
  • Patient followed for the management of cancer, hospitalized or not, receiving or having already received a treatment cancer administered orally and / or systemically.

Exclusion Criteria

  • Patient who has not been treated for cancer with anticancer treatment
  • Support in a palliative care service
  • Refusal to participate in the study
  • Patient under tutorship or curatorship
  • Patient deprived of liberty

Outcomes

Primary Outcomes

Evaluation of the perception of patients regarding complementary and alternative medicines (CAM) in the management of cancer or its complications but also the place of different health professionals.

Time Frame: Time of inclusion

This evaluation is carried out using a semi-directed interview, then a questionnaire

Secondary Outcomes

  • Number of iatrogenic risks related to CAM and chemotherapy(Time of inclusion)
  • Number of factors influencing the consumption of CAM(Time of inclusion)
  • Number of the CAM supply sources(Time of inclusion)
  • Identification of the roles of health professionals in the patient's treatment process to help secure information about CAM(Time of inclusion)
  • Prevalence of CAM used in cancer patients(Time of inclusion)
  • Number of the information sources used by patients(Time of inclusion)

Study Sites (1)

Loading locations...

Similar Trials